Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Confirmatory study of TRK-820 Soft Capsules-Intractable Pruritus in Patients with Chronic Liver Disease-

Next Previous
Trial Profile

Confirmatory study of TRK-820 Soft Capsules-Intractable Pruritus in Patients with Chronic Liver Disease-

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nalfurafine (Primary)
  • Indications Pruritus
  • Focus Therapeutic Use
  • Sponsors Toray

    • Most Recent Events

    • 01 Sep 2017 Primary endpoint (STEP I, The difference in changes in VAS (week 4 [LOCF]) between the placebo and 5 microgram groups) has been met, according to result published in the Hepatology Research.
    • 01 Sep 2017 Primary endpoint (STEP II, The difference in changes in VAS (week 4 [LOCF]) between the placebo and 2.5 microgram groups) has been met, according to result published in the Hepatology Research.
    • 01 Sep 2017 Results assessing the efficacy and safety of the nalfurafine hydrochloride in the treatment of refractory pruritus in patients with chronic liver disease, were published in the Hepatology Research.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top